| 17.77 0.24 (1.37%) | 04-28 11:22 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 20.86 | 1-year : | 24.36 |
| Resists | First : | 17.86 | Second : | 20.86 |
| Pivot price | 17.43  |
|||
| Supports | First : | 17.1 | Second : | 16.63 |
| MAs | MA(5) : | 17.51 |
MA(20) : | 17.36 |
| MA(100) : | 17.49 |
MA(250) : | 18.52  |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 80.5 |
D(3) : | 74.5 |
| RSI | RSI(14): 56.1 |
|||
| 52-week | High : | 24.13 | Low : | 13.68 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ KVUE ] has closed It is unclear right now based on current values. 54.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 17.67 - 17.76 | 17.76 - 17.84 |
| Low: | 17.18 - 17.28 | 17.28 - 17.37 |
| Close: | 17.37 - 17.52 | 17.52 - 17.67 |
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Tue, 28 Apr 2026
Vest Financial LLC Has $56.02 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Tue, 28 Apr 2026
Vanguard Group Inc. Buys 1,604,040 Shares of Kenvue Inc. $KVUE - MarketBeat
Tue, 28 Apr 2026
Kenvue Stock: Is Wall Street Bullish or Bearish? - Barchart.com
Mon, 27 Apr 2026
Renaissance Capital LLC Lowers Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Mon, 27 Apr 2026
91,331 Shares in Kenvue Inc. $KVUE Bought by Camelot Portfolios LLC - MarketBeat
Mon, 27 Apr 2026
Why Kenvue Inc. (KVUE) is One of the Best Cheap Stocks to Buy Under $20 - Yahoo Finance UK
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 1,920 (M) |
| Shares Float | 1,910 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 95.9 (%) |
| Shares Short | 61,700 (K) |
| Shares Short P.Month | 66,800 (K) |
| EPS | 0.75 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.61 |
| Profit Margin | 9.7 % |
| Operating Margin | 17.8 % |
| Return on Assets (ttm) | 6.6 % |
| Return on Equity (ttm) | 14.3 % |
| Qtrly Rev. Growth | 3.2 % |
| Gross Profit (p.s.) | 4.59 |
| Sales Per Share | 7.87 |
| EBITDA (p.s.) | 1.68 |
| Qtrly Earnings Growth | 11.1 % |
| Operating Cash Flow | 2,200 (M) |
| Levered Free Cash Flow | 1,810 (M) |
| PE Ratio | 23.33 |
| PEG Ratio | 1.5 |
| Price to Book value | 3.15 |
| Price to Sales | 2.25 |
| Price to Cash Flow | 15.47 |
| Dividend | 0.2 |
| Forward Dividend | 0 |
| Dividend Yield | 1.1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|